| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |